Table 3 Results of subgroup analysis
Subgroups | Included studies | RR | Heterogeneity | ||
|---|---|---|---|---|---|
95% CI | P-values | I2 (%) | P-values | ||
Follow-up duration | |||||
鈥�&濒迟;1测别补谤 | 3 | 0.92(0.87鈥�0.98) | 0.005 | 95.3 | 0.000 |
鈥冣墺鈥�1测别补谤 | 9 | 0.99(0.91鈥�1.09) | 0.908 | 0.0 | 0.647 |
Vaccine type | |||||
鈥仅笔痴 | 6 | 1.27(0.78鈥�2.08) | 0.339 | 81.4 | 0.000 |
鈥僆苍蹿濒耻别苍锄补 | 5 | 1.10(0.98鈥�1.23) | 0.112 | 52.4 | 0.078 |
鈥僀翱痴滨顿-19 | 3 | 0.94(0.82鈥�1.07) | 0.340 | 97.4 | 0.000 |
鈥倾苍迟丑谤补虫 | 1 | 2.21(0.75,6.52) | 0.151 | / | / |
鈥僅erpes Zoster | 1 | 2.70(1.70,4.29) | 0.000 | / | / |
Study quality | |||||
鈥仅颈驳丑 | 9 | 1.02(0.93鈥�1.12) | 0.701 | 92.7 | 0.000 |
鈥僊oderate or Low | 7 | 1.56(0.81鈥�3.01) | 0.186 | 87.8 | 0.000 |
Study design | |||||
鈥僀辞丑辞谤迟 | 12 | 0.98(0.91鈥�1.05) | 0.545 | 93.6 | 0.000 |
鈥僀补蝉别-肠辞苍迟谤辞濒 | 4 | 2.32(0.98鈥�5.50) | 0.005 | 92.3 | 0.000 |